| abstract |
Provided is a new therapeutic drug useful as a preventive or therapeutic agent for constipation, which contains, as an active ingredient, a compound inhibiting SGLT1, particularly 4-isopropylphenylglucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof do. |